1
|
Potaczek T, Jasiewicz B. How back pain influences daily activities and quality of life: Incidence of back pain related to age. J Child Orthop 2023; 17:505-511. [PMID: 38050592 PMCID: PMC10693836 DOI: 10.1177/18632521231215855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Accepted: 11/03/2023] [Indexed: 12/06/2023] Open
Abstract
Low back pain is a prevalent global musculoskeletal issue, with a lifetime prevalence ranging from 49% to 70% in adults. Traditionally associated with adults, recent field surveys indicate comparable prevalence rates in children and adolescents, challenging earlier assumptions. Non-specific low back pain, where the source cannot be identified through diagnostic imaging, accounts for about 80%-90% of cases. Studies have shown that over 80% of adolescents with low back pain exhibit no underlying pathology. The prevalence of low back pain in younger populations varies widely, influenced by study methodology, age, and pain types. Research suggests that back pain prevalence in adolescents increases with age, with a shift in attitudes considering it is not necessarily indicative of specific issues. Level of evidence: level V.
Collapse
Affiliation(s)
- Tomasz Potaczek
- Department of Orthopaedics and Rehabilitation, Jagiellonian University Medical College, Zakopane, Poland
| | - Barbara Jasiewicz
- Department of Orthopaedics and Rehabilitation, Jagiellonian University Medical College, Zakopane, Poland
| |
Collapse
|
2
|
Kaiser L, Neugebauer EAM, Pieper D. Interprofessional collaboration and patient-reported outcomes: a secondary data analysis based on large scale survey data. BMC Health Serv Res 2023; 23:5. [PMID: 36597063 PMCID: PMC9809039 DOI: 10.1186/s12913-022-08973-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2022] [Accepted: 12/15/2022] [Indexed: 01/05/2023] Open
Abstract
BACKGROUND While interprofessional collaboration (IPC) is widely considered a key element of comprehensive patient treatment, evidence focusing on its impact on patient-reported outcomes (PROs) is inconclusive. The aim of this study was to investigate the association between employee-rated IPC and PROs in a clinical inpatient setting. METHODS We conducted a secondary data analysis of the entire patient and employee reported data collected by the Picker Institute Germany in cross-sectional surveys between 2003 and 2016. Individual patient data from departments within hospitals was matched with employee survey data from within 2 years of treatment at the department-level. Items assessing employee-rated IPC (independent variables) were included in Principal Component Analysis (PCA). All questions assessing PROs (overall satisfaction, less discomforts, complications, treatment success, willingness to recommend) served as main dependent variables in ordered logistic regression analyses. Results were adjusted for multiple hypothesis testing as well as patients' and employees' gender, age, and education. RESULTS The data set resulted in 6154 patients from 19 hospitals respective 103 unique departments. The PCA revealed three principal components (department-specific IPC, interprofessional organization, and overall IPC), explaining 67% of the total variance. The KMO measure of sampling adequacy was .830 and Bartlett's test of sphericity highly significant (p < 0.001). An increase of 1 SD in department-specific IPC was associated with a statistically significant chance of a higher (i.e., better) PRO-rating about complications after discharge (OR 1.07, 95% CI 1.00-1.13, p = 0.029). However, no further associations were found. Exploratory analyses revealed positive coefficients of department-specific IPC on all PROs for patients which were treated in surgical or internal medicine departments, whereas results were ambiguous for pediatric patients. CONCLUSIONS The association between department-level IPC and patient-level PROs remains - as documented in previous literature - unclear and results are of marginal effect sizes. Future studies should keep in mind the different types of IPC, their specific characteristics and possible effect mechanisms. TRIAL REGISTRATION Study registration: Open Science Framework (DOI https://doi.org/10.17605/OSF.IO/2NYAX ); Date of registration: 09 November 2021.
Collapse
Affiliation(s)
- Laura Kaiser
- grid.412581.b0000 0000 9024 6397Witten/Herdecke University, Witten, Germany
| | | | - Dawid Pieper
- grid.412581.b0000 0000 9024 6397Witten/Herdecke University, Witten, Germany ,Institute for Research in Operative Medicine, Witten, Germany ,grid.473452.3Institute for Health Services and Health Systems Research, Brandenburg Medical School Theodor Fontane, Rüdersdorf, Germany ,grid.473452.3Center for Health Services Research, Brandenburg Medical School Theodor Fontane, Rüdersdorf, Germany ,Faculty of Health Sciences Brandenburg, Potsdam, Germany
| |
Collapse
|
3
|
Pougheon Bertrand D, Fanchini A, Lombrail P, Rault G, Chansard A, Le Breton N, Frenod C, Milon F, Heymes-Royer C, Segretain D, Silber M, Therouanne S, Haesebaert J, Llerena C, Michel P, Reynaud Q. Collaborative research protocol to define patient-reported experience measures of the cystic fibrosis care pathway in France: the ExPaParM study. Orphanet J Rare Dis 2022; 17:73. [PMID: 35193621 PMCID: PMC8861995 DOI: 10.1186/s13023-022-02204-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2021] [Accepted: 02/06/2022] [Indexed: 11/21/2022] Open
Abstract
Introduction In France, the cystic fibrosis (CF) care pathway is coordinated by multidisciplinary teams from specialised CF centres or transplant centres. It includes the care provided at home or out of hospital, risk prevention in daily life and adjustments to social life, which together contribute to the person’s quality of life. Patient experience is used to describe and evaluate the care and life of patients living with the disease. Objectives Our collaborative research aims to identify the most significant areas and criteria that characterise the CF pathway. It will lead to the development of a questionnaire to collect patients' experience, which can be administered to all patients or parents of children registered and followed in the centres. The article describes the protocol developed in partnership with patients and parents of children living with the disease. Method A multidisciplinary research group brings together researchers, patients, parents of children with CF and health care professionals. The patient partnership is involved in the 4 phases of the protocol: (1) setting up the study, recruiting patient and parent co-researchers, training them in qualitative research methods, defining the situations and profiles of patients in the study population, elaborating the protocol; (2) selecting the study sites, recruiting participants, carrying out semi-structured interviews, analysing verbatims using the grounded theory approach; (3) co-elaborating Patient-Reported Experience Measures (PREM) questionnaires adapted to the 4 types of participants: parents, adolescents, non-transplanted adults and transplanted adults; (4) validating the construct with participants and professionals from the study centres. Results The protocol obtained a favourable opinion from the Ethics Evaluation Committee of INSERM (IRB00003888—no. 20-700). Training was provided to the 5 patients and 2 parent co-researchers to enable them to participate effectively in the research. Eleven centres participated in the recruitment of participants in mainland France and Reunion Island. Eighty hours of interviews were conducted. Discussion The PREM questionnaires to be elaborated will have to undergo psychometric validation before being used by the actors of the CF network to assess the impact on the care pathways of quality approaches or new therapies available in cystic fibrosis. Trial Registration Registry: IRB00003888 – no. 20-700. Issue date: 06/09/2020.
Collapse
Affiliation(s)
- D Pougheon Bertrand
- Laboratory of Education and Health Practices (LEPS) UR3412, Sorbonne Paris Nord University, Villetaneuse, France.
| | - A Fanchini
- Laboratory of Education and Health Practices (LEPS) UR3412, Sorbonne Paris Nord University, Villetaneuse, France
| | - P Lombrail
- Laboratory of Education and Health Practices (LEPS) UR3412, Sorbonne Paris Nord University, Villetaneuse, France
| | - G Rault
- Laboratory of Education and Health Practices (LEPS) UR3412, Sorbonne Paris Nord University, Villetaneuse, France
| | - A Chansard
- Cystic Fibrosis Patient and Parent Co-Investigators Group, Paris, France
| | - N Le Breton
- Cystic Fibrosis Patient and Parent Co-Investigators Group, Paris, France
| | - C Frenod
- Cystic Fibrosis Patient and Parent Co-Investigators Group, Paris, France
| | - F Milon
- Cystic Fibrosis Patient and Parent Co-Investigators Group, Paris, France
| | - C Heymes-Royer
- Cystic Fibrosis Patient and Parent Co-Investigators Group, Paris, France
| | - D Segretain
- Cystic Fibrosis Patient and Parent Co-Investigators Group, Paris, France
| | - M Silber
- Cystic Fibrosis Patient and Parent Co-Investigators Group, Paris, France
| | - S Therouanne
- Centre de Ressources et de Compétences mucoviscidose, CHU Lille, Lille, France
| | - J Haesebaert
- Laboratory RESHAPE U. INSERM 1290, Claude Bernard Lyon 1 University, Villeurbanne, France
| | - C Llerena
- Centre de Ressources et de Compétences mucoviscidose, Hôpital Couple-Enfants, Grenoble, France
| | - P Michel
- Laboratory RESHAPE U. INSERM 1290, Claude Bernard Lyon 1 University, Villeurbanne, France.,Quality and Security Department, Hospices Civils de Lyon, Lyon, France
| | - Q Reynaud
- Laboratory RESHAPE U. INSERM 1290, Claude Bernard Lyon 1 University, Villeurbanne, France.,Centre de Ressources et de Compétences mucoviscidose, Hôpital Lyon Sud, Pierre-Bénite, France
| |
Collapse
|
4
|
Pougheon Bertrand D, Minguet G, Gagnayre R, Lombrail P. Lessons from patient and parent involvement (P&PI) in a quality improvement program in cystic fibrosis care in France. Orphanet J Rare Dis 2018; 13:19. [PMID: 29799378 PMCID: PMC6225648 DOI: 10.1186/s13023-017-0751-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND Quality Improvement Programs (QIP) in cystic fibrosis (CF) care have emerged as strategies to reduce variability of care and of patient outcomes among centres facilitating the implementation of Best Practices in all centres. The US CF Foundation developed a Learning and Leadership Collaborative program which was transposed in France in 2011. Patient and parent involvement (P&PI) on the local quality teams (QTs) is one dimension of this complex intervention. The conditions and effects of this involvement needed to be evaluated. METHODS In all settings, patients and parents were recruited by their centre care team. They were trained to QI method and tools and contributed their own expertise to improve the process of care. This involvement has been analyzed in the frame of the whole process evaluation. Observations and interviews conducted during the course of the first training year explored the motivations of the patients and parents to participate and the vision of the health care teams. A research study was carried out after three years with the patients/parents and the professionals to assess the French QIP's effectiveness using a questionnaire to report their opinions on various components of the program, including their experience of P&PI. Responses were analyzed in view of identifying consensus and dissensus between the two groups. RESULTS At the introduction of the program, P&PI was an opportunity for healthcare providers to reflect on their conceptions of these individuals both as patients and as healthcare system users. Curiosity about the teams' functioning, the various center organizations and outcomes led patients to overcome their initial barriers to participation. Seventy-six people including 12 patients/parents from the 14 pilot centres responded to the questionnaire after 3 years. Consensus between professionals and patients/parents was high on most items characterizing the performance of the QIP, QT effectiveness and QT functioning. Patients, parents and professionals agreed on the main characteristics of care such as an optimized organization, multidisciplinary care and patient-centredness. Regarding the use of patient electronic records, the use of care guidelines or the organization of support in the patient community, responses were not consensual amongst patients/parents and a source of dissensus between the two groups. All agreed that the French QIP created good conditions for their involvement. In the end, both groups agreed that it was difficult to attribute the paternity of some changes specifically to any member in the team. DISCUSSION Perspectives such as an educational framework to develop the skills and behaviors of professionals engaged in collaborative practice with patients and families and large patient experience surveys could be used to capture patients' experience of care in the improvement work. CONCLUSION Success factors for patient/parent long-term involvement in QIPs have been identified. Answers to questions raised by the stakeholders about the feasibility, efficiency and usefulness of P&PI in this CF QIP could be given but new questions arose about the sustainability of continuous quality improvement over time.
Collapse
Affiliation(s)
| | | | - Rémi Gagnayre
- LEPS EA3412, Sorbonne Paris Cité University, Bobigny, France
| | - Pierre Lombrail
- LEPS EA3412, Sorbonne Paris Cité University, Bobigny, France
| |
Collapse
|
5
|
Ellemunter H, Stahl K, Smrekar U, Steinkamp G. Evaluating patient experience in a cystic fibrosis centre using a disease-specific patient satisfaction questionnaire. Eur J Pediatr 2015; 174:1451-60. [PMID: 25944680 DOI: 10.1007/s00431-015-2545-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2014] [Revised: 03/28/2015] [Accepted: 04/14/2015] [Indexed: 12/01/2022]
Abstract
UNLABELLED Medical care for persons with chronic diseases like cystic fibrosis (CF) is provided by multi-professional teams. We assessed the patients' perspective of care by reporting the results of two consecutive patient satisfaction surveys performed within a 2-year interval at our CF centre. The newly developed, disease-specific questionnaire for parents and adults had 104 items with up to 6 response categories each. For data analysis, responses were dichotomized into a problem score with 0 % as the ideal result. Adolescents were surveyed using a different questionnaire. Seventy-six and 89 respondents, respectively, took part in the 2009 and 2011 surveys (response rates: 72 to 84 %). In 2009, the ideal problem score of 0 % was reported for 18 and 20 % of all items in adults and parents, respectively. Thirteen items had a problem score >30 %. After the whole team had implemented quality improvement measures, the 2011 survey showed a >10 % decrease in problem scores for 11 and 21 % of items in the adults and parents groups, respectively. Adolescents also reported better experiences in 2011 than in 2009. CONCLUSION Exploring the patients' perspectives aids to identify strengths and weaknesses and helps to provide patient-centred care, which is important for persons with chronic illness.
Collapse
Affiliation(s)
- Helmut Ellemunter
- CF Centre, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria. .,Division of Cardiology, Pulmonology, Allergology, Cystic Fibrosis, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
| | - Katja Stahl
- Picker Institut Deutschland gGmbH, Kieler Str. 2, 22769, Hamburg, Germany.
| | - Ulrike Smrekar
- CF Centre, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria. .,Department of Medical Psychology, Medical University of Innsbruck, Schöpfstraße 23a, 6020, Innsbruck, Austria.
| | - Gratiana Steinkamp
- CF Centre, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria. .,Clinical Research, Reutzstr. 1, 19055, Schwerin, Germany.
| |
Collapse
|
6
|
Steinkamp G, Ellemunter H, Schwarz C, Stahl K. Different approaches to evaluate patient experience and satisfaction in CF centres. J Cyst Fibros 2015; 14:E19-20. [PMID: 26071056 DOI: 10.1016/j.jcf.2015.05.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2015] [Revised: 05/26/2015] [Accepted: 05/27/2015] [Indexed: 11/16/2022]
|